Related Experiment Video
Updated: May 6, 2026

10:52
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
10.6K
Plasmablastic Lymphoma Masquerading as Plasma Cell Myeloma: A Case Report
Mouad Harandou1, Mohammed Bensalah1, Rachid Seddik1
1Hematology, Mohammed VI University Hospital, Mohammed First University, Oujda, MAR.
Cureus
|February 13, 2025
Summary
Plasmablastic lymphoma (PBL) is a rare, aggressive B-cell cancer often seen in immunocompromised individuals. This case highlights an unusual extra-oral, Epstein-Barr virus-negative PBL in an elderly patient, emphasizing diagnostic challenges.
Area of Science:
- Oncology
- Hematology
- Pathology
Background:
- Plasmablastic lymphoma (PBL) is an aggressive B-cell neoplasm, primarily affecting immunocompromised individuals, notably those with human immunodeficiency virus (HIV).
- PBL typically presents in the oral cavity and is frequently associated with Epstein-Barr virus (EBV) infection.
- Distinguishing PBL from other B-cell and plasma cell neoplasms is challenging due to shared morphology, particularly in rare EBV-negative and extra-oral presentations.
Observation:
- A 72-year-old patient with a prior diagnosis of plasma cell myeloma presented with aggressive, refractory disease progression.
- Histomorphological and immunohistochemical investigations revealed an unusual extra-oral, EBV-negative Plasmablastic Lymphoma.
- Rapid disease progression, lymphadenopathy, and plasmablastic morphology raised suspicion for PBL.
Findings:
- The case presented an atypical manifestation of Plasmablastic Lymphoma, occurring outside the oral cavity and without EBV association.
- Diagnostic challenges were encountered due to the overlapping morphology with other plasma cell and B-cell malignancies.
- The patient's history of plasma cell myeloma complicated the diagnostic pathway.
Implications:
- Accurate diagnosis of PBL, especially in extra-oral and EBV-negative cases, requires thorough histopathological and immunohistochemical evaluation.
- Clinical correlation is crucial for differentiating PBL from other hematologic malignancies.
- This case underscores the importance of considering rare presentations of aggressive lymphomas in elderly patients, even with prior diagnoses.

